FDA May Allow "Qualitative" Labels For Data In DTC Ads
This article was originally published in The Pink Sheet Daily
Executive Summary
Study of "format variations" in the brief summary of print advertisements will test different ways of presenting benefit and risk information.
You may also be interested in...
FDA’s Biggest DTC Advertising Study Eyes Online Promotion
The agency has 11 research projects under way, including a $2 million study of online Rx drug promotion; pharma spending on direct-to-consumer advertising declined in 2012 with biggest spends on Cymbalta and Cialis ads.
Can't Please Everybody: FDA's "Brief Summary" Redesign May Require Flexibility
Drug Facts Box format scored well in a broad study, but researchers found it may not be the best format for everyone.
Can't Please Everybody: FDA's "Brief Summary" Redesign May Require Flexibility
Drug Facts Box format scored well in a broad study, but researchers found it may not be the best format for everyone.